Dow Up 1.05% Nasdaq Up 0.57%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
6.44 Down 0.24(3.59%) 10:38AM EST - Nasdaq Real Time Price
Prev Close:6.68
Open:6.72
Bid:6.42 x 100
Ask:6.45 x 100
1y Target Est:11.25
Beta:0.938812
Earnings Date:Mar 3 - Mar 7 (Est.)
Day's Range:6.32 - 6.72
52wk Range:5.87 - 23.67
Volume:19,268
Avg Vol (3m):275,719
Market Cap:221.88M
P/E (ttm):153.33
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OSIR

Comparison

Symbol% ChgMkt Cap
OSIRDown 3.59%221.88M
UCBJY 0.00%14.87B
BIIBDown 0.27%53.45B
ABTUp 0.39%54.42B

Key Statistics

Forward P/E (1 yr):49.38
P/S (ttm):2.66
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.08
Quarterly EPS Est (Dec-15) :0.06
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback